| Entry |
|
|---|
| Name |
Taprenepag (USAN/INN) |
|---|
| Formula |
C24H22N4O5S
|
|---|
| Exact mass |
478.1311
|
|---|
| Mol weight |
478.52
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiglaucoma, Intraocular pressure lowering agent, Prostaglandin E2 receptor agonist |
|---|
| Comment |
Non-prostanoid prostaglandin receptor agonist
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostaglandin
PTGER2
D09968 Taprenepag (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 34
1 C8y C 15.6100 -34.0900
2 C8x C 15.6100 -35.4900
3 C8x C 16.8000 -36.1900
4 C8y C 17.9900 -35.4900
5 C8x C 17.9900 -34.0900
6 C8x C 16.8000 -33.3900
7 C1b C 19.2500 -36.2600
8 N1c N 20.4400 -35.5600
9 C1b C 21.6300 -36.1900
10 C8y C 22.8200 -35.4900
11 C8x C 24.0100 -36.1900
12 C8x C 25.2700 -35.4900
13 C8x C 25.2700 -34.0900
14 C8y C 24.0800 -33.3900
15 C8x C 22.8200 -34.0900
16 S4a S 20.4400 -34.0900
17 C8y C 20.4400 -32.6900
18 O3c O 21.8400 -34.0900
19 O3c O 19.0400 -34.0900
20 C8x C 21.6300 -31.9900
21 C8x C 21.6300 -30.5900
22 C8x C 20.4400 -29.8900
23 N5x N 19.2500 -30.5900
24 C8x C 19.2500 -31.9900
25 O2a O 24.0800 -31.9900
26 C1b C 25.2700 -31.2900
27 C6a C 26.5300 -31.9900
28 O6a O 27.7200 -31.2900
29 O6a O 26.5300 -33.3900
30 N4y N 14.3947 -33.3949
31 N5x N 14.4495 -31.9903
32 C8x C 13.1343 -31.5049
33 C8x C 12.2662 -32.6057
34 C8x C 13.0449 -33.7715
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 14 15 1
16 10 15 2
17 8 16 1
18 16 17 1
19 16 18 2
20 16 19 2
21 17 20 2
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 17 24 1
27 14 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 27 29 2
32 1 30 1
33 30 31 1
34 31 32 2
35 32 33 1
36 33 34 2
37 30 34 1
|
|---|
